Literature DB >> 91512

Chemical and biological properties of bleomycin labelled with 57Co.

P Raban, J Brousil, P Svihovcová.   

Abstract

The chemical composition of bleomycin labelled with 57Co and its distribution and kinetics in the organs of tumour bearing rats were studied. For separating bleomycin, the chromatography on a CM-Sephadex C-25 column with a gradient of ammonium formate was found to be most suitable. It is also possible to use paper chromatography in 10% NH4Cl and thin layer chromatography in 10% ammonium acetate with methyl alcohol 1:1. The fractions obtained by the chromatographic separation were identified as A2, B2 and A1. Labelling with 57Co given rise to a more complicated mixture of labelled compounds, all of them differing chromatographically from the original non-labelled components. Using carrier-free 57Co two main radioactive compounds are formed apparently corresponding to the fractions A2 and B2 containing one atom of Co per molecule. The amount of another two labelled components grows progressively with increasing amount of carrier CoCl2. Since their chromatographic properties are even more different from those of the original compounds, it was concluded that they probably contain two atoms of Co in their molecules. During distribution studies, rapid excretion of labelled bleomycin into the urine and stool was observed. Increased activities were retained in the liver, kidney, intestine and tumour.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91512     DOI: 10.1007/BF00620484

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  [Metabolism of bleomycin labled with a divalent cation. 2. Study of urinary metabolites in the rat and comparative study of tissue elimination of the cation alone or chelated by bleomycin].

Authors:  J Rapin; H Renault; J Robert; M Rudler; J P Nouel
Journal:  Therapie       Date:  1973 Sep-Oct       Impact factor: 2.070

2.  Studies on bleomycin: chemistry and the biological action.

Authors:  H Umezawa
Journal:  Biomedicine       Date:  1973-11

3.  [Cobalt-57 labeled bleomycin metabolism in the mouse. 1. Distribution and Kinetics].

Authors:  J Robert; H Renault; J Rapin; M Rudler; J P Nouel
Journal:  Therapie       Date:  1973 Sep-Oct       Impact factor: 2.070

4.  Distribution of labeled bleomycin in normal and tumor-bearing mice.

Authors:  R B Grove; W C Eckelman; R C Reba
Journal:  J Nucl Med       Date:  1973-12       Impact factor: 10.057

5.  Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.

Authors:  M A van de Poll; A Versluis; J J Rasker; H Jurjens; M G Woldring
Journal:  Nuklearmedizin       Date:  1976-04       Impact factor: 1.379

6.  Purification of bleomycins.

Authors:  H Umezawa; Y Suhara; T Takita; K Maeda
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

7.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.

Authors:  J J Rasker; A M Poll; H Beekhuis; M G Woldring; H O Nieweg
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

8.  Chemical and biologic properties of isolated radiolabeled bleomycin preparations.

Authors:  W C Eckelman; W J Rzeszotarski; B A Siegel; H Kubota; M Chelliah; J Stevenson; R C Rebra
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

9.  Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.

Authors:  R B Grove; R C Reba; W C Eckelman; M Goodyear
Journal:  J Nucl Med       Date:  1974-06       Impact factor: 10.057

10.  Comparison of uptake of 67Ga-citrate and 57Co-bleomycin in tumor using a semiconductor detector.

Authors:  T Higashi; M Kanno; K Tomura
Journal:  J Nucl Med       Date:  1974-12       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.